Work

Abstract 3011: Novel CDK12 inhibitors with preclinical anti-tumor activity and best-in-class profile on HER2 low breast cancer patient samples

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3011

Authors: Chandan Seth Nanda, Maria New, Angela Velentza-Almpani, Julio Martinez-Torres, Nourdine K. Bah, Niamh A. Leonard, Farah A. Sangkolah, Keqian K. Nan, Eleonora Peerani, Duleek Ranatunga

Institution: Ourotech Limited (United Kingdom)

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409625278

Cites:

Cited by:

Related to: 10